Suchergebnisse - "Van de Werf, Frans"

PubPharm (738)

1

Response by Van de Werf et al to Letter Regarding Article, "STREAM-2 : Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial"

enthalten in: Circulation | 2024

von Van de Werf, F. | Sinnaeve, P. | Welsh, R. | +1

CommentOn: Circulation. 2024 Feb 27;149(9):725-726. - PMID 38408148

2

Rationale and design of the ESC Heart Failure III Registry - Implementation and discovery

enthalten in: European journal of heart failure | 2023

von Lund, L. | Crespo-Leiro, M. | Laroche, C. | +119

3

Impact of standard modifiable cardiovascular risk factors on 2-year all-cause mortality : Insights from an international cohort of 23,489 patients with acute coronary syndrome

enthalten in: American heart journal | 2023

von González-Del-Hoyo, M. | Rossello, X. | Peral, V. | +8

4

Impact of Complete Revascularization in the ISCHEMIA Trial

enthalten in: Journal of the American College of Cardiology | 2023

von Stone, G. | Ali, Z. | O'Brien, S. | +127

CommentIn: J Am Coll Cardiol. 2023 Sep 19;82(12):1189-1191. - PMID 37704308

5

STREAM-2 : Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial

enthalten in: Circulation | 2023

von Van de Werf, F. | Ristić, A. | Averkov, O. | +18

CommentIn: Circulation. 2024 Feb 27;149(9):725-726. - PMID 38408148

6

Polypill Strategy in Secondary Cardiovascular Prevention

enthalten in: The New England journal of medicine | 2022

von Castellano, J. | Pocock, S. | Bhatt, D. | +144

CommentIn: N Engl J Med. 2022 Sep 15;387(11):1034-1036. - PMID 36018010

7

Sex differences in mortality after an acute coronary syndrome increase with lower country wealth and higher income inequality

enthalten in: Revista espanola de cardiologia (English ed.) | 2022

von Rossello, X. | Mas-Lladó, C. | Pocock, S. | +8

8

Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor : Findings From CHAMPION PHOENIX

enthalten in: Circulation. Cardiovascular interventions | 2022

von Cavender, M. | Harrington, R. | Stone, G. | +112

CommentIn: Circ Cardiovasc Interv. 2022 Jul;15(7):e012098. - PMID 35861799

9

Do clinical trial data suggest a role for SGLT2-inhibitors in primary prevention of heart failure and chronic kidney disease?

enthalten in: International journal of cardiology. Cardiovascular risk and prevention | 2021

von Staessen, J. | Janssens, S. | Van de Werf, F.

10

Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial

enthalten in: Journal of the American Heart Association | 2021

von Bergmark, B. | Bhatt, D. | Steg, P. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[74]